Zhejiang Haisen Pharmaceutical Co., Ltd. (SHE:001367)
China flag China · Delayed Price · Currency is CNY
23.60
-0.58 (-2.40%)
Feb 2, 2026, 4:00 PM EST

SHE:001367 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Dec '21 Dec '20
Operating Revenue
509.37470.54396.28421.14386.79283.41
Other Revenue
0.970.971.171.642.191.39
510.33471.51397.45422.78388.98284.8
Revenue Growth (YoY)
17.50%18.63%-5.99%8.69%36.58%6.94%
Cost of Revenue
289.55281.91237.4266.52236.12173.83
Gross Profit
220.79189.6160.05156.26152.87110.97
Selling, General & Admin
50.6440.6535.7232.2532.9427.19
Research & Development
38.1127.7818.8415.7712.0710.83
Other Operating Expenses
6.814.364.162.133.112.59
Operating Expenses
97.0372.8859.1551.2447.8539.97
Operating Income
123.76116.72100.9105.02105.0271
Interest Expense
-0.35-0.37-0.03-0.07-0.1-
Interest & Investment Income
11.6118.4115.623.552.254.22
Currency Exchange Gain (Loss)
3.323.320.878.37-2.17-3.76
Other Non Operating Income (Expenses)
0.02-0.24-0.190.05-0.4-0.3
EBT Excluding Unusual Items
138.36137.85117.17116.93104.5971.17
Gain (Loss) on Sale of Investments
----3.850.74-
Gain (Loss) on Sale of Assets
-0.27--0.24---
Asset Writedown
-1.04-1.23-0.96-1.21-0.67-0.24
Other Unusual Items
6.785.114.7111.913.862.64
Pretax Income
143.89141.79120.68123.78108.5273.57
Income Tax Expense
20.0819.2316.0116.1914.5210.75
Net Income
123.82122.56104.67107.599462.83
Net Income to Common
123.82122.56104.67107.599462.83
Net Income Growth
3.45%17.09%-2.72%14.46%49.62%-8.89%
Shares Outstanding (Basic)
148149137112112112
Shares Outstanding (Diluted)
152150137112112112
Shares Change (YoY)
1.21%9.35%22.74%-0.02%--0.16%
EPS (Basic)
0.830.820.760.960.840.56
EPS (Diluted)
0.820.820.760.960.840.56
EPS Growth
2.21%7.09%-20.74%14.68%49.60%-8.89%
Free Cash Flow
2.66102.4123.1754.7673.7255.48
Free Cash Flow Per Share
0.020.680.170.490.660.50
Dividend Per Share
0.1150.1150.228---
Dividend Growth
-49.65%-49.65%----
Gross Margin
43.26%40.21%40.27%36.96%39.30%38.96%
Operating Margin
24.25%24.75%25.39%24.84%27.00%24.93%
Profit Margin
24.26%25.99%26.33%25.45%24.16%22.06%
Free Cash Flow Margin
0.52%21.72%5.83%12.95%18.95%19.48%
EBITDA
140.62131.76113.52118.59117.3781.64
EBITDA Margin
27.56%27.94%28.56%28.05%30.17%28.67%
D&A For EBITDA
16.8615.0412.6213.5612.3510.64
EBIT
123.76116.72100.9105.02105.0271
EBIT Margin
24.25%24.75%25.39%24.84%27.00%24.93%
Effective Tax Rate
13.95%13.56%13.26%13.08%13.38%14.61%
Revenue as Reported
510.33471.51397.45422.78388.98284.8
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.